KRT8 Antikörper
-
- Target Alle KRT8 Antikörper anzeigen
- KRT8 (Keratin 8 (KRT8))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KRT8 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- KLH conjugated Synthetic peptide corresponding to Mouse Cytokeratin 8
- Isotyp
- IgG
- Top Product
- Discover our top product KRT8 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:200-1:800
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 430 μg/mL
- Buffer
- PBS with 0.02 % sodium azide, 1 % BSA and 50 % glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- KRT8 (Keratin 8 (KRT8))
- Andere Bezeichnung
- CK-8 (KRT8 Produkte)
- Hintergrund
- Cytokeratin 8 (CK8) has a molecular weight of 52.5 KDa, which belongs to the HMW (high molecular weight) B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.
- Molekulargewicht
-
Observed_MW: 54 kDa
Calculated_MW: 54 kDa
- UniProt
- P05787, P11679, Q10758
-